Brief: LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
29/12/2023 21:49
Dec 29 (Reuters) - LumiraDx Ltd LMDX.O :
* LUMIRADX ANNOUNCES AGREEMENT TO SELL ITS CUTTING EDGE
POINT OF
CARE TECHNOLOGY PLATFORM TO ROCHE
* LUMIRADX LTD - UNDER TERMS OF AGREEMENT, AT CLOSING OF
TRANSACTION ROCHE WILL PAY A PURCHASE PRICE OF USD 295 MILLION
* LUMIRADX LTD - ADDITIONAL PAYMENT OF UP TO $55 MILLION FOR
REIMBURSEMENT OF AMOUNTS TO FUND POINT OF CARE DIAGNOSTICS
PLATFORM BUSINESS UNTIL DEAL CLOSE
Source text for Eikon: ID:nGNXbRxh4T
Further company coverage: LMDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LumiraDx
See all newsBrief: LumiraDx Announces Its Securities Will Be Suspended From Trading On Nasdaq At The Open Of Business On January 9Th
Roche to buy part of LumiraDx diagnostics platform for $295 million
Brief: LumiraDx- Under Terms Of Certain Loan Agreement, Dated March 23, 2021, The Waiver Period Has Expired As Of Today
Brief: LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
Brief: Willard L. Umphrey Reports 10.31% Stake In Lumiradx Limited As Of Dec 22- SEC Filing